Catch up on our latest news and developments from the first half of 2021

No images? Click here

Domainex - Enrich your medicines pipeline
 

Domainex News

All the latest news and industry insights from the Domainex team

 
 
Tom Mander, CEO, Domainex

Tom Mander, CEO

OBN Awards winners celebrate international collaboration

It’s hard to believe we’re already at the end of Q2, but after another hectic few months here at Domainex, we’ve collated our highlights from the last quarter. As always, please let us know if you’d like to opt out of receiving our newsletters.

We were thrilled to be awarded ‘Best CRO’ at the OBN Awards and I would like to thank our team for their consistent hard work and positive can-do approach while facing the additional challenges created by the pandemic.

Domainex has grown significantly in the last 12-18 months against a challenging background. Fuelled by a diverse workforce, our international growth strategy has resulted in our overseas customers now outweighing our UK customers for the first time. To reflect the importance of this international collaboration in scientific research, we have translated key sections of our website to better communicate with our clients. The French, German, Italian and Spanish sections are now live and we look forward to further expanding our languages in the coming months.

As always, thank you to our fantastic team and to our clients, both new and old. We look forward to many more interesting projects as the summer continues.

Tom
E: Tom.Mander@dominex.co.uk

Domainex wins Best CRO at OBN Awards

We were delighted to be awarded ‘Best CRO’ at the postponed OBN Awards 2020, recognising our excellent customer focus. The award also acknowledged Domainex’s achievements and innovations in the life sciences industry as part of a continued effort to meet previously unmet clinical needs. 

CEO Tom Mander collects the Best CRO award at the OBN Awards
Read the full article
 
domainex international collaboration

All the Nations

We are celebrating international collaboration with our team, suppliers and clients to drive innovation and accelerate drug discovery research. Read more.

 
Growing Pains panel at Bio Integrates

How do you plan, implement and adapt your growth strategy?

Tom Mander joined the 'Growing Pains' panel at Bio Integrates to discuss some of the challenges that growing life sciences organisations face. Read more.

 
New recruits to the team

Expanding our talented team

We're thrilled to welcome Dr Badri Rajagopal, Senior Scientist, Protein Science, Dr Kartika Shetty, Senior Scientist, Assay Biology and Helen Hallmark, Commercial Team Assistant. We're always looking for talented new team members, check out our current vacancies to find out more.

New publications

How do you choose between HTS, virtual screening and FBDD?

Meet the Domainex team: Sam Braidley

Tom Mander introduces Domainex's Medicines Research Centre in a new video

Multiplexed in vitro models of primary human B cell activation

Multiplexed in vitro models of primary human T cell activation

 

Follow us on social media

TwitterLinkedIn

Upcoming events

ON Helix
5th July 2021

XXVI EFMC International Symposium on Medicinal Chemistry
28th August 2021

21st RSC / SCI Medicinal chemistry symposium
13-15th September 2021

BioForward
23rd September 2021

What medicinal chemists need to know about biology II
27-28th September 2021

Start your next project with Domainex

Contact one of our experts today
 
 
  Share 
  Tweet 
  Share 
  Forward 
Domainex is a registered company (number 4336899)
Chesterford Research Park
Little Chesterford
Saffron Walden, Essex
CB10 1XL, UK
Preferences  |  Unsubscribe